Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Secondino

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Critical Reviews in Oncology/Hematology|June 9, 2019
Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis: An Associazione Italiana di Oncologia Medica (AIOM)/Societa' Italiana di Nefrologia (SIN) multidisciplinary consensus position paperNicola Silvestris, Antonella Argentiero, Laura Cosmai, et al.
Cancers|July 29, 2023
Clinical Trials of Cellular Therapies in Solid TumorsSimona Secondino, Costanza Canino, Domiziana Alaimo, et al.
ESMO Open|December 7, 2017
Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN)Paolo Pedrazzoli, Nicola Silvestris, Antonio Santoro, et al.
Critical Reviews in Oncology/Hematology|July 19, 2025
Novel androgen receptor inhibitors in prostate cancer: What do we know so far?Francesca Rifaldi, Anna Tortorella, Silvio Sporeni, et al.
Bone Marrow Transplantation|January 26, 2018
Secondary malignancies after high-dose chemotherapy in germ cell tumor patients: a 34-year retrospective study of the European Society for Blood and Marrow Transplantation (EBMT)Andrea Necchi, Salvatore Lo Vullo, Simona Secondino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytesPatrizia Comoli, Paolo Pedrazzoli, Rita Maccario, et al.
Haematologica|March 7, 2007
Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow TransplantationSimona Secondino, Matteo G Carrabba, Paolo Pedrazzoli, et al.
Life (Basel, Switzerland)|January 21, 2023
Ovarian Cancer Radiosensitivity: What Have We Understood So Far?Amelia Barcellini, Alexandra Charalampopoulou, Loris De Cecco, et al.
Clinical and Translational Radiation Oncology|May 10, 2024
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancerAmelia Barcellini, Kazutoshi Murata, Giulia Fontana, et al.
Anticancer Research|March 6, 2020
Is Proton Beam Radiotherapy Worthwhile in the Management of Angiosarcoma of the Scalp?Viviana Vitolo, Amelia Barcellini, Alfredo Mirandola, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Critical Reviews in Oncology/Hematology|June 9, 2019
Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis: An Associazione Italiana di Oncologia Medica (AIOM)/Societa' Italiana di Nefrologia (SIN) multidisciplinary consensus position paperNicola Silvestris, Antonella Argentiero, Laura Cosmai, et al.
Cancers|July 29, 2023
Clinical Trials of Cellular Therapies in Solid TumorsSimona Secondino, Costanza Canino, Domiziana Alaimo, et al.
ESMO Open|December 7, 2017
Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN)Paolo Pedrazzoli, Nicola Silvestris, Antonio Santoro, et al.
Critical Reviews in Oncology/Hematology|July 19, 2025
Novel androgen receptor inhibitors in prostate cancer: What do we know so far?Francesca Rifaldi, Anna Tortorella, Silvio Sporeni, et al.
Bone Marrow Transplantation|January 26, 2018
Secondary malignancies after high-dose chemotherapy in germ cell tumor patients: a 34-year retrospective study of the European Society for Blood and Marrow Transplantation (EBMT)Andrea Necchi, Salvatore Lo Vullo, Simona Secondino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytesPatrizia Comoli, Paolo Pedrazzoli, Rita Maccario, et al.
Haematologica|March 7, 2007
Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow TransplantationSimona Secondino, Matteo G Carrabba, Paolo Pedrazzoli, et al.
Life (Basel, Switzerland)|January 21, 2023
Ovarian Cancer Radiosensitivity: What Have We Understood So Far?Amelia Barcellini, Alexandra Charalampopoulou, Loris De Cecco, et al.
Clinical and Translational Radiation Oncology|May 10, 2024
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancerAmelia Barcellini, Kazutoshi Murata, Giulia Fontana, et al.
Anticancer Research|March 6, 2020
Is Proton Beam Radiotherapy Worthwhile in the Management of Angiosarcoma of the Scalp?Viviana Vitolo, Amelia Barcellini, Alfredo Mirandola, et al.
Pageof 5